Medtronic has completed the divestiture of its MiniMed assets and received notice of insider stock sales
Medtronic has completed an exchange of shares for its interest in MiniMed Group, accepting 55,032,401 of its own shares. This action completes the company's divestiture of all remaining interest in MiniMed.
Key points
- Medtronic accepted a total of 55,032,401 of its own shares, including 5,975,762 additional shares it elected to accept due to high demand.
- Previously, in September 2026, the company announced the start of an offer to exchange up to 225,361,295 MiniMed shares, representing approximately 80.1% of that company's capital.
Exchange offer results.
Medtronic accepted a total of 55,032,401 of its own shares, including 5,975,762 additional shares it elected to accept due to high demand. A total of 252,813,348 shares of MiniMed Group were exchanged for these securities. The exchange agent calculated that 297,521,390 Medtronic shares were validly tendered.
Due to high demand, the company applied a proration procedure to participants. The final proration factor was 18.289133%. An exception was made for odd-lot holders (an odd-lot is a holding of fewer than 100 shares, which are not subject to proration), allowing them to avoid adjustment of the number of shares exchanged.
Proposed sales (Form 144), by insider
Deal context.
Previously, in September 2026, the company announced the start of an offer to exchange up to 225,361,295 MiniMed shares, representing approximately 80.1% of that company's capital. Terms set a ratio of 4.5939 MiniMed shares for each Medtronic share received.
Insider intentions and next steps.
In addition to completing the exchange, two insiders reported intentions to sell Medtronic shares on October 15, 2026. Martha Geoffrey plans to sell 50,000 shares under a trading plan adopted in July 2026. Michael Marinaro filed a notice of intent to sell 10,420 shares. A notice of intent to sell shares does not mean the sale has already occurred.
Original sources
- SC TO-I/A filing, October 13, 2026
- SC TO-I/A filing, October 14, 2026
- 144 filing, October 15, 2026
- 144 filing, October 15, 2026
- 8-K filing, September 17, 2026
- SC TO-I/A filing, October 8, 2026
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Medtronic
A notification in your browser or on your phone when we publish about Medtronic. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
